Xencor | Attività Correnti



Current Assets Cambiamento Data
AbbVie USD 25.58B 2.2B 2024-12
Alnylam Pharmaceuticals USD 3.3B 60.14M 2024-12
Amgen USD 29.03B 2.26B 2024-12
Arrowhead Research USD 570.54M 124.93M 2024-12
AstraZeneca USD 25.83B 1.67B 2024-12
Biogen USD 7.46B 626.3M 2024-12
Bristol-Myers Squibb USD 29.78B 1.7B 2024-12
Cytokinetics USD 1.11B 89.34M 2024-12
GlaxoSmithKline GBP 17B 301M 2024-12
J&J USD 55.89B 2.64B 2024-12
MacroGenics USD 222.2M 65.24M 2024-09
Merck USD 38.78B 1.58B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pfizer USD 50.36B 7.14B 2024-12
Regeneron Pharmaceuticals USD 27.21B 7.88B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Xencor USD 577.6M 4.27M 2024-12



Xencor Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.